EASL Studio S06E11 - Assessment of significant portal hypertension in 2024
EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?
EASL Studio S4 Special Edition - A new strategy for liver cancer screening
EASL Studio S7E09 - TIPS: How far can we go?
EASL Studio - S3E15 - Chronic portal vein thrombosis
EASL Studio S6E5 - JHEP Live: Should the cACLD concept replace cirrhosis?
EASL Studio S9E5 - Does it really matter whether we call it ACLF or acute decompensation?
EASL Studio S8E1 - Update on Steatotic Liver Disease: Rethinking Standard of Care
EASL Studio S8E14 - Steatotic Liver Disease Unpacked: Targeting Dynamic Risks
EASL Studio S6E9 - JHEP Live: Therapy hierarchy in HCC: A new kid on the block
EASL Studio S4E19 - HDV: The devil becomes treatable
EASL Studio - Regenerative Hepatology: From stem cells to tissue engineering
EASL Studio S9E9 - Rifaximin for Hepatic Encephalopathy
EASL Studio S8E15 - EASL CPGs on Vascular Liver Diseases: What’s New?
EASL Studio S9E11 - What Can Be Done to Safeguard Young Adults from SLD?
EASL Studio S6E4 - World Cholangiocarcinoma Day
EASL Studio S6E8 - Is there a role for measuring blood ammonia in patients with cirrhosis?
EASL Studio at ILC 2022 - Thursday 23 June - Teatime
EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner?
EASL Studio - JHEP Live - The best animal model for HCC – lost in translation?
